Aligos Therapeutics (ALGS) Short Interest Ratio & Short Volume → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free ALGS Stock Alerts $0.69 +0.03 (+4.56%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Aligos Therapeutics Short Interest DataCurrent Short Volume838,500 sharesPrevious Short Volume657,200 sharesChange Vs. Previous Month+27.59%Dollar Volume Sold Short$641,452.50Short Interest Ratio / Days to Cover2.2Last Record DateApril 30, 2024Outstanding Shares78,110,000 sharesPercentage of Shares Shorted1.07%Today's Trading Volume884,261 sharesAverage Trading Volume196,789 sharesToday's Volume Vs. Average449% Short Selling Aligos Therapeutics ? Sign up to receive the latest short interest report for Aligos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALGS Short Interest Over TimeALGS Days to Cover Over TimeALGS Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Aligos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024838,500 shares $641,452.50 +27.6%N/A2.2 $0.77 4/15/2024657,200 shares $587,996.84 -24.4%N/A1.7 $0.89 3/31/2024868,800 shares $851,424.00 +137.6%N/A2.3 $0.98 3/15/2024365,600 shares $336,900.40 -1.0%N/A0.9 $0.92 2/29/2024369,100 shares $365,409.00 +16.4%N/A0.8 $0.99 2/15/2024317,100 shares $203,578.20 -64.6%N/A0.8 $0.64 Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024894,500 shares $617,205.00 +6.4%N/A3 $0.69 1/15/2024840,400 shares $619,458.84 -1.7%N/A2.8 $0.74 12/31/2023855,200 shares $567,852.80 -1.1%N/A3.1 $0.66 12/15/2023864,400 shares $505,760.44 +14.2%N/A4.1 $0.59 11/30/2023756,900 shares $529,830.00 +4.4%2.4%4.6 $0.70 11/15/2023724,800 shares $456,624.00 -1.3%2.3%9.2 $0.63 10/31/2023734,600 shares $440,760.00 -3.4%4.1%10.1 $0.60 10/15/2023760,700 shares $562,918.00 +1.0%2.8%10.8 $0.74 9/30/2023753,300 shares $562,715.10 -1.6%2.8%10.7 $0.75 9/15/2023765,200 shares $612,160.00 +0.6%2.9%10.1 $0.80 8/31/2023761,000 shares $655,221.00 +2.6%2.9%7.7 $0.86 8/15/2023742,100 shares $693,863.50 -4.5%2.8%6.9 $0.94 7/31/2023776,800 shares $691,352.00 -3.3%2.8%3.5 $0.89 7/15/2023803,500 shares $827,605.00 -1.7%2.9%3.8 $1.03 6/30/2023817,600 shares $793,889.60 +4.1%3.0%3.9 $0.97 6/15/2023785,700 shares $864,270.00 -14.3%2.9%3.7 $1.10 5/31/2023917,000 shares $1.04 million +25.0%3.4%4.5 $1.13 5/15/2023733,500 shares $953,550.00 -5.3%2.7%3.6 $1.30 4/30/2023774,500 shares $898,420.00 -0.3%2.8%7.7 $1.16 4/15/2023776,800 shares $722,346.32 -6.8%2.8%5.8 $0.93 3/31/2023833,000 shares $728,042.00 -4.4%3.0%2.8 $0.87 3/15/2023871,200 shares $1.17 million +2.0%3.3%2.2 $1.34 2/28/2023853,900 shares $1.25 million +16.2%2.9%2.1 $1.46 2/15/2023735,100 shares $1.19 million +0.7%2.5%1.8 $1.62 1/31/2023730,300 shares $1.42 million +128.4%2.7%1.8 $1.94 1/15/2023319,800 shares $524,472.00 -17.6%1.2%0.9 $1.64 12/30/2022387,900 shares $369,629.91 -3.5%1.4%1.8 $0.95 12/15/2022402,100 shares $381,995.00 +3.2%1.5%4.6 $0.95 11/30/2022389,500 shares $389,500.00 -7.1%1.4%5.2 $1.00 11/15/2022419,300 shares $427,686.00 +17.6%1.5%5.7 $1.02 10/31/2022356,700 shares $374,535.00 +1.1%1.6%4.8 $1.05 10/15/2022353,000 shares $388,300.00 +4.6%1.6%4.5 $1.10 9/30/2022337,600 shares $371,360.00 -13.5%1.5%3.4 $1.10 9/15/2022390,300 shares $519,099.00 +11.7%1.7%2.6 $1.33Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… ALGS Short Interest - Frequently Asked Questions What is Aligos Therapeutics' current short interest? Short interest is the volume of Aligos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 838,500 shares of ALGS short. Learn More on Aligos Therapeutics' current short interest. What is a good short interest ratio for Aligos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALGS shares currently have a short interest ratio of 2.0. Learn More on Aligos Therapeutics's short interest ratio. Which institutional investors are shorting Aligos Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aligos Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Aligos Therapeutics' short interest increasing or decreasing? Aligos Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 838,500 shares, an increase of 27.6% from the previous total of 657,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aligos Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Aligos Therapeutics: AVROBIO, Inc. (0.42%), Genenta Science S.p.A. (0.03%), IN8bio, Inc. (0.60%), Cidara Therapeutics, Inc. (2.04%), Dyadic International, Inc. (0.96%), OKYO Pharma Limited (0.43%), Cyclo Therapeutics, Inc. (0.35%), Ikena Oncology, Inc. (5.99%), Quince Therapeutics, Inc. (6.58%), MiNK Therapeutics, Inc. (0.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aligos Therapeutics stock? Short selling ALGS is an investing strategy that aims to generate trading profit from Aligos Therapeutics as its price is falling. ALGS shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aligos Therapeutics? A short squeeze for Aligos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALGS, which in turn drives the price of the stock up even further. How often is Aligos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALGS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AVROBIO Short Squeeze Genenta Science Short Squeeze IN8bio Short Squeeze Cidara Therapeutics Short Squeeze Dyadic International Short Squeeze OKYO Pharma Short Squeeze Cyclo Therapeutics Short Squeeze Ikena Oncology Short Squeeze Quince Therapeutics Short Squeeze MiNK Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALGS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap Profits